GENERIC IMATINIB VS GLEEVEC

QR Code

GENERIC IMATINIB VS GLEEVEC

Enregistré dans:

Détails bibliographiques
Auteur principal:	Katia Borgia Barbosa Pagnano
Format:	article
Langue:	EN
Publié:	Elsevier 2021
Sujets:	Diseases of the blood and blood-forming organs RC633-647.5
Accès en ligne:	https://doaj.org/article/de67607d56cc435281a4dcb48c05cd57
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose
par: Waclaw J, et autres
Publié: (2015)

Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
par: Natalia Estrada, et autres
Publié: (2021)

Long-term safety and efficacy of dasatinib in the treatment of chronic-phase chronic myeloid leukemia patients resistant or intolerant to imatinib
par: Shoumariyeh K, et autres
Publié: (2014)

Bortezomib in autoimmune hemolytic anemia and beyond
par: Raffaella Pasquale, et autres
Publié: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
par: Monarch Shah, et autres
Publié: (2021)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
par: Eko A. Pangarsa, et autres
Publié: (2021)

PP Transcon 2020 Abstracts Compilation
Publié: (2021)

Positive/external control of rapid diagnostic tests: A step forward in malaria screening
par: Rasika D Setia, et autres
Publié: (2021)

A rare case of mistaken identity - Historical blood group saved the situation
par: Anand Deshpande, et autres
Publié: (2021)

Oration - Dr Sanmukh Joshi
Publié: (2021)

OP Transcon 2020 Abstracts Compilation
Publié: (2021)

TRANSCON 2020 45th Annual Conference ISBTI 27th & 28th Feb 2021
Publié: (2021)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
par: Vijeta Bajpai, et autres
Publié: (2021)

Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
par: Samuel sarmiento Doncel, et autres
Publié: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
par: Brian Eyden, et autres
Publié: (2021)

Regulation of megakaryopoiesis by bone marrow macrophage polarization
par: Ming Hou
Publié: (2021)

The correlation between Flt3-ITD mutation in dendritic cells with TIM-3 expression in acute myeloid leukemia
par: Hooriyeh Shapoorian, et autres
Publié: (2021)

Immune targeted therapy for diffuse large B cell lymphoma
par: Yaxin Zheng, et autres
Publié: (2021)

Lymphoid-biased hematopoietic stem cells and myeloid-biased hematopoietic progenitor cells have radioprotection activity
par: Shanshan Zhang, et autres
Publié: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
par: Meletios A. Dimopoulos, et autres
Publié: (2021)

De Novo AL Amyloidosis in Renal Allograft and Anti-CD38 Monoclonal Antibody Treatment
par: Despina Fotiou, et autres
Publié: (2021)

Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
par: Achille Iolascon, et autres
Publié: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
par: Julio Delgado, et autres
Publié: (2021)

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
par: Hans C. Hasselbalch, et autres
Publié: (2021)

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies
par: Natali Pflug, et autres
Publié: (2021)

Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
par: Colin Vercueil, et autres
Publié: (2021)

Azacytidine Treatment for VEXAS Syndrome
par: Marc H. G. P. Raaijmakers, et autres
Publié: (2021)

tiRNA Join Hematopoietic Niches
par: Melania Tesio
Publié: (2021)

Improvement of Standardization of Molecular Analyses in Hematology: The 10-year GBMHM French Experience
par: Anne Sophie Alary, et autres
Publié: (2021)

The EHA Research Roadmap: Normal Hematopoiesis
par: Thierry Jaffredo, et autres
Publié: (2021)

HSP70 and FLT3-ITD: Targeting chaperone system to overcome drug resistance
par: Jing Yang, et autres
Publié: (2021)

Small nucleolar RNA is potential as a novel player in leukemogenesis and clinical application
par: Li-Min Lin, et autres
Publié: (2021)

The Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular seeks the implementation of, and access to, the CAR-T cell treatment in Brazil
par: Dante Mário Langhi Junior, et autres
Publié: (2021)

Derivation of a Pharmacokinetic Model to Include a Plasma-Derived, von Willebrand Factor-Containing Factor VIII (Koate-DVI) Concentrate and its Low-Dose Use
par: Dagmar M. Hajducek, et autres
Publié: (2021)

Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States
par: Rory M. Shallis, et autres
Publié: (2021)

External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
par: Pierre Chelle, et autres
Publié: (2021)

Falsely positive heparin‐induced thrombocytopenia antibody testing in severe hyperbilirubinemia
par: Daniel Egert, et autres
Publié: (2021)

A Rare Cause of Acquired Factor X Deficiency in an 87-Year-Old Female
par: Ayrton Bangolo, et autres
Publié: (2021)

Reticulocyte Hemoglobin Equivalent: Diagnostic Performance in Assessment of Iron Deficiency in Patients with Hypothyroidism
par: Wardah Aslam, et autres
Publié: (2021)

Daratumumab plus CyBorD for patients with newly diagnosed light chain (AL) amyloidosis
par: Foteini Theodorakakou, et autres
Publié: (2021)